Sai Life Sciences Limited — Important, 09-06-2025: Updates

Sai Life Sciences addressed concerns on its ESOP 2008 and 2018 schemes, confirming exercise prices align with past investments, avoiding deep discount issuance. The company clarified no current associates hold ESOPs but aims for approval flexibility in the future. On the appointment of Dr. Dinesh V Patel as an independent director, Sai Life stressed full compliance with independence norms, noting his shareholding is well below the 2% limit and highlighting thorough board evaluation before his nomination.